Zobrazeno 1 - 10
of 478
pro vyhledávání: '"David Mackintosh"'
Autor:
Sheahan-Bright, Robyn
Publikováno v:
Magpies; May2011, Vol. 26 Issue 2, p4-8, 5p
Autor:
Deborah Stevenson
Publikováno v:
Bulletin of the Center for Children's Books. 68:215-215
Publikováno v:
Internal Medicine Journal. 50:603-611
Neutropenic fever is a frequently encountered complication when caring for cancer patients and can lead to intensive care admission, with high mortality rates in those patients who require invasive mechanical ventilation (IMV). Although hospital surv
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:266-269
We report on the unique case of a patient with antisynthetase syndrome and metastatic non-small cell lung cancer undergoing therapy with the PD-1 checkpoint inhibitor, nivolumab. Despite adequate autoimmune disease control over a period of 12 months,
Autor:
David, Mackintosh
Publikováno v:
The American Journal of Dental Science
Autor:
David MacKintosh
Publikováno v:
Annals of Palliative Medicine. 6:S257-S259
Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia and known to be effective in the management of delirium. In addition to its use for these indications olanzapine has also been used in the management of chemotherapy
Autor:
Charlotte E. Edling, Aileen King, Fadel Lhaf, Hemant M. Kocher, Natasha J. Hill, Anthony J. Walker, Malin Flodström-Tullberg, David Mackintosh, Peter B. Jones, Rosemary McNeice, Claire L. Ryall, Katrina Viloria
Publikováno v:
Journal of Biological Chemistry. 289:30614-30624
Understanding the mechanisms regulating islet growth and survival is critical for developing novel approaches to increasing or sustaining β cell mass in both type 1 and type 2 diabetes patients. Secreted protein acidic and rich in cysteine (SPARC) i
Publikováno v:
Progress in Palliative Care. 23:88-91
IntroductionOpioid switching in the management of cancer-related pain is a widely used strategy which relies heavily on the use of published equianalgesic ratios despite acknowledged difficulties which include serious toxicity. Agreement on appropria
Autor:
Angus G. Dalgleish, Nikolaos Ioannou, David Mackintosh, Helmout Modjtahedi, Alan M. Seddon, Flavio Solca
Publikováno v:
International Journal of Oncology
Drug-resistance is a major contributing factor for the poor prognosis in patients with pancreatic cancer. We have shown previously that the irreversible ErbB family blocker afatinib, is more effective than the reversible EGFR tyrosine kinase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66573afe967467e7be635dcba1d819f9
https://eprints.kingston.ac.uk/id/eprint/34658/1/Ioannou-N-34658-VoR.pdf
https://eprints.kingston.ac.uk/id/eprint/34658/1/Ioannou-N-34658-VoR.pdf